NasdaqGM - Nasdaq Real Time Price USD

Hyperfine, Inc. (HYPR)

0.7300

-0.0143

(-1.92%)

At close: May 12 at 4:00:00 PM EDT

0.7486

+0.02

+(2.55%)

After hours: May 12 at 7:10:19 PM EDT

Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025

GUILFORD, Conn., April 29, 2025--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the first quarter 2025 on Tuesday, May 13, 2025. Management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Business Wire 13 days ago

HYPR
-1.92%
Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices

GUILFORD, Conn., April 15, 2025--Study examines clinical utility and patient experience of AI-powered portable MRI in neurology offices.

Business Wire 27 days ago

HYPR
-1.92%
Hyperfine Full Year 2024 Earnings: In Line With Expectations

Hyperfine ( NASDAQ:HYPR ) Full Year 2024 Results Key Financial Results Revenue: US$12.9m (up 17% from FY 2023). Net...

Simply Wall St. last month

HYPR
-1.92%
March 2025's Top Penny Stocks To Watch

The U.S. equities market has hit a pause on its recent recovery, with major indices like the Dow Jones and S&P 500 experiencing declines amid ongoing economic uncertainties and geopolitical tensions. Despite these broader market challenges, investors continue to seek opportunities in various sectors, including the often-overlooked realm of penny stocks. Though considered a relic by some, penny stocks remain relevant for their potential to offer significant returns when backed by strong...

Simply Wall St. last month

HFFG

GEVO

HYPR
-1.92%
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

GUILFORD, Conn., March 17, 2025 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced fourth quarter and full year 2024 financial results and provided a business update. “I am pleased with the many milestones we achieved in the fourth quarter of 2024. These set the stage well for us to execute on

GlobeNewswire last month

HYPR
-1.92%
Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation

GUILFORD, Conn., March 17, 2025--Hyperfine and NVIDIA collaboration aims to make portable MRI faster, smarter, and more accessible worldwide.

Business Wire last month

HYPR
-1.92%
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

GUILFORD, Conn., March 04, 2025--Hyperfine, Inc. will report financial results for the fourth quarter and full year 2024 on Monday, March 17, 2025.

Business Wire 2 months ago

HYPR
-1.92%
Hyperfine Announces $6.0 Million Registered Direct Offering

GUILFORD, Conn., February 11, 2025--Hyperfine, Inc. (Nasdaq: HYPR) ("Hyperfine" or the "Company") today announced it has entered into a definitive agreement with investors for the purchase and sale of 4,511,278 shares of the Company’s Class A common stock and warrants to purchase up to 4,511,278 shares of Class A common stock. Each share of Class A common stock and accompanying warrant were sold together at a combined offering price of $1.33 in a registered direct offering. The warrants have an

Business Wire 2 months ago

HYPR
-1.92%
Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference

GUILFORD, Conn., February 06, 2025--Hyperfine reports on new data at ISC 2025 showcasing the growing potential for using images from AI-powered portable MRI for stroke diagnosis.

Business Wire 3 months ago

HYPR
-1.92%
US Penny Stocks To Consider In February 2025

As January 2025 comes to a close, the United States stock market has seen its share of ups and downs, with major indexes posting gains despite recent tariff announcements. For investors looking beyond the well-known giants, penny stocks—often representing smaller or newer companies—can offer intriguing possibilities. Although the term "penny stocks" may seem outdated, these investments remain relevant today as they can provide unique opportunities for growth and value that larger firms might...

Simply Wall St. 3 months ago

HYPR
-1.92%

LVO

KLTR
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates

Preliminary unaudited revenue expected to be between $21.0 million and $21.5 million for Q4 2024, and between $79.4 million and $79.9 million for full year 2024 Scott Huennekens Appointed to NeuroPace Board of Directors effective January 6th Management presenting at the 43rd Annual J.P. Morgan Healthcare Conference on January 15th Company to host an Investor Day on January 28th in New York City MOUNTAIN VIEW, Calif., Jan. 08, 2025 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical dev

GlobeNewswire 4 months ago

HYPR
-1.92%

NPCE

NVST
CytoMed Therapeutics Leads 3 US Penny Stocks To Consider

As the U.S. equities market begins 2025 on a challenging note, extending its recent slump, investors are keenly observing potential opportunities amid broader market declines. Penny stocks, despite their vintage moniker, continue to attract attention for those interested in smaller or newer companies with potential value. This article explores three penny stocks that stand out for their financial strength and balance sheet resilience, offering intriguing possibilities for investors seeking...

Simply Wall St. 4 months ago

GDTC

HYPR
-1.92%
Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets

GUILFORD, Conn., December 17, 2024--Hyperfine, Inc. announces global expansion of commercial operations into Turkey, Israel and Saudi Arabia to support Swoop® system expansion plans.

Business Wire 4 months ago

HYPR
-1.92%
Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care

GUILFORD, Conn., December 05, 2024--Hyperfine highlights data and conclusions from eleven abstracts presented at the Radiological Society of North America 2024 Annual Meeting in Chicago.

Business Wire 5 months ago

HYPR
-1.92%
Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals

GUILFORD, Conn., December 03, 2024--Strategic appointments position Hyperfine to drive the adoption of the Swoop® system in hospital settings and expand into the office setting

Business Wire 5 months ago

HYPR
-1.92%
US Penny Stocks To Consider In November 2024

As the U.S. stock market experiences a rise, with major indexes on track for weekly gains and Bitcoin reaching new all-time highs, investors are exploring diverse opportunities in various segments. Penny stocks, despite being an older term, continue to attract interest due to their potential for value and growth that larger firms might overlook. This article will explore three penny stocks with strong financials that could offer stability and upside potential for investors interested in...

Simply Wall St. 5 months ago

HYPR
-1.92%

VGZ

GSIT
Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body

GUILFORD, Conn., November 21, 2024--The new MRI standards by the IAC, effective immediately, now include portable MR scanning at the point of care.

Business Wire 5 months ago

HYPR
-1.92%
Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings

GUILFORD, Conn., November 19, 2024--Hyperfine, Inc. announces ten scientific abstracts highlighting ultra-low-field imaging will be presented at the RSNA 2024 Annual Meeting.

Business Wire 5 months ago

HYPR
-1.92%
Hyperfine Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line

Hyperfine ( NASDAQ:HYPR ) Third Quarter 2024 Results Key Financial Results Revenue: US$3.64m (up 56% from 3Q 2023). Net...

Simply Wall St. 5 months ago

HYPR
-1.92%
Is Hyperfine (NASDAQ:HYPR) In A Good Position To Invest In Growth?

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Simply Wall St. 5 months ago

HYPR
-1.92%

Performance Overview

Return	HYPR	S&P 500 (^GSPC)
YTD	-17.05%	-0.64%
1-Year	-7.59%	+11.90%
3-Year	-65.40%	+48.70%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Hyperfine, Inc. (HYPR)

Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025

Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices

Hyperfine Full Year 2024 Earnings: In Line With Expectations

March 2025's Top Penny Stocks To Watch

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Hyperfine Announces $6.0 Million Registered Direct Offering

Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference

US Penny Stocks To Consider In February 2025

NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2024 and Provides Business Updates

CytoMed Therapeutics Leads 3 US Penny Stocks To Consider

Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets

Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care

Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals

US Penny Stocks To Consider In November 2024

Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body

Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings

Hyperfine Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS In Line

Is Hyperfine (NASDAQ:HYPR) In A Good Position To Invest In Growth?

Performance Overview